CancerWorld

When the first signals of modern immunotherapy began to emerge a little over a decade ago, many of us realised that oncology was about to change forever. I still remember the sense of astonishment when we saw the first durable…

Oncology has seen tremendous progress over the last few decades. Yet, for advanced solid cancers, some new treatments offer only a few weeks of survival benefit. Meanwhile, the amount of time spent in pursuing these new treatments can be substantial.…

For decades, cancer treatment has been anchored firmly within hospital walls, where the complexity and risks of chemotherapy seemed inseparable from clinical infrastructure. But as newer, less toxic therapies emerge, a quiet revolution is taking shape: the idea that certain…

Where progress is redesigned with purpose and delivered back to those who need it most Every issue of CancerWorld explores the places where science meets humanity, where personal stories reshape public systems, and where progress in oncology is defined not…

At 17, Annet Namubiru’s life changed drastically. Then a secondary school student, she began to fall ill without anyone understanding why. “I was at school and started feeling weak and tired,” she recalls. “As you know, when a girl of…

Workplace discrimination remains one of the most persistent and underrecognized challenges faced by individuals diagnosed with cancer. While advances in treatment have significantly improved survival rates and quality of life, many patients and survivors encounter a different kind of battle…

“Cancer is like a stallion: either you ride the stallion, or the stallion is going to ride on you.” — Shrenik Shah, Stage IV Laryngeal Cancer Survivor, 6x TEDx Speaker & Global Goodwill Ambassador When I step on the stage,…

Many people diagnosed with cancer often wonder what “caused” their disease and whether they could have done anything to prevent it. Typically, the risk of developing cancer is determined by a combination of genetics and environmental exposures, causing errors in…

An AI model has been trained using mammograms to identify breast cancer patients who could be spared from unnecessary lymph node biopsy procedures. The study, published in NPJ Digital Medicine, 10 July, found that the introduction of the AI model…

Imagine an oncologist stepping out of tumor board and into clinic with a complex case at hand. The patient’s tumor has multiple high-risk features, genomic mutations, and borderline indications for therapy. In the past, the doctor might sift through guidelines,…